Funding for this research was provided by:
Viatris Pharmaceuticals Japan, Inc.
Article History
Accepted: 11 May 2022
First Online: 20 June 2022
Declarations
:
: This work was supported by Viatris Pharmaceuticals Japan, Inc.
: KN is an employee of Viatris Pharmaceuticals Japan, Inc. MI and SK declare that they have no competing interests.
: This observational study solely used secondary data, which were processed to be fully anonymized and contained no personal information. An observational study exclusively using anonymized data is outside the scope of the Ethical Guidelines for Medical and Health Research Involving Human Subjects by the Japanese Government. Therefore, ethical committee approval and individual informed consent were not required for this study in accordance with consultation of the ethics committee at Aichi Medical University.
: Not applicable.
: Not applicable.
: The dataset analyzed in this study are not publicly available because they were obtained from a commercial company, Medical Data Vision Co., Ltd., and used under license. However, data may be available from the corresponding author on reasonable request and with permission from Medical Data Vision Co., Ltd.
: Not applicable.
: All authors made substantial contributions to (1) the conception and design of the study, (2) analysis or interpretation of data, and (3) drafting or revising the manuscript critically for important intellectual content. All authors approved the final version of the manuscript to be submitted.